A randomized double-blind controlled exploratory study comparing CS-8958 to oseltamivir phosphate in patients with influenza virus infection (Phase 2)

Trial Profile

A randomized double-blind controlled exploratory study comparing CS-8958 to oseltamivir phosphate in patients with influenza virus infection (Phase 2)

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2016

At a glance

  • Drugs Laninamivir (Primary) ; Oseltamivir
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Sponsors Biota Holdings; Daiichi Sankyo Company
  • Most Recent Events

    • 31 Jul 2008 Active comparator identified as oseltamivir in a Biota Holdings media release.
    • 31 Jul 2008 Status changed from unconfirmed to completed, as reported by Biota Holdings.
    • 20 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top